
Bulletin of the Chemical Society of Japan p. 3457 - 3464 (1985)
Update date:2022-08-04
Topics:
Nakata
Toshima
Kai
Kinoshita
The improved practical synthesis of 6,8,10-tri-O-acetyl-3-C-(acetoxymethyl)-3,5,7,9,11-pentadeoxy-1,2-O-isopro pylidene-5,7,9,11-tetra-C-methyl-L-erythro-D-altro-β-L-talo-dodecodialdof uranose-(1,4) 12-(diethyl acetal) (3), a useful synthetic segment for the rifamycin W ansa-chain, is described. The key intermediate, 3-O-benzyl-2,4,7-trideoxy-5,6-O-isopropylidene-2,4-di-C-methyl-aldehydo-D- glycero-D-allo-heptose (22), was synthesized in a 29.4% yield from methyl 4,6-O-benzylidene-3-deoxy-3-C-methyl-α-D-altropyranoside (8) in 15 steps. The coupling of 22 with the lithium reagent prepared from butyllithium and 3-C-(benzyloxymethyl)-3,5,6-trideoxy-5-iodo-1,2-O-isopropylidene-α-D-ribo -5-hexenofuranose afforded only the 'Cram' product 24 in a 61% yield. The homogeneous hydrogenation of 24 with [RhCl(Ph3P)3] gave 8-O-benzyl-3-C-(benzyloxymethyl)-3,5,7,9,12-pentadeoxy-1,2:5,6-di-O-isopro pylidene-5,7,9-tri-C-methyl-D-erythro-D-altro-L-talo-dodecofuranose-(1,4) (25) and its C-5 epimer in 95 and 3.8% yields respectively. 6,8-Di-O-benzyl-3-C-(benzyloxymethyl)-3,5,7,9-tetradeoxy-1,2-O-isopropylid ene-5,7,9-tri-C-methyl-D-altro-β-L-talo-decodialdofuranose-(1,4), derived from 25 in a 91% yield, was subjected to coupling with 3,3-diethoxy-2-lithio-1-propene to afford about 1.7:1 excess of the 'Cram' product (30, 59% yield). The conversion of 30 into 3 was accomplished by the sequence of reactions involving homogeneous hydrogenation, debenzylation, and acetylation in a 75% yield. The 24-step synthesis of 3 from 8 was achieved in a 7% overall yield.
View MoreJiande City Silibase Silicone New Material Manufacture Co., Ltd.
Contact:15967177856
Address:Genglou Industrial Development Area
Jewim Pharmaceutical (Shandong) Co., Ltd
Contact:+8615621883869
Address:山东省泰安市高新技术产业开发区配天门大街西首
Huangshi Meifeng Chemical Co.,ltd.
Contact:+86-714-6516706
Address:1941-4-3#,Hubin Avenue,Huangshi,Hubei,China
Wuhan Fortuna Chemical Co.,Ltd
website:http://www.fortunachem.com
Contact:86-27-59207850
Address:Add: Room 2015, No.2 Building, Kaixin Mansion No.107 Jinqiao Avenue, Wuhan, China
Changchun BC&HC Pharmaceutical Technology Co.,Ltd
Contact:+86-0431-80871588, +86-0431-80871788
Address:NO.668#Chuangxin road, Gaoxin District, Changchun ,Jilin
Doi:10.1016/j.bmc.2008.05.031
(2008)Doi:10.1016/j.tetlet.2008.04.130
(2008)Doi:10.1021/ol801358c
(2008)Doi:10.1016/S0040-4039(00)83948-9
(1986)Doi:10.1007/s10593-007-0140-8
(2007)Doi:10.1021/ol800902g
(2008)